By analyzing the risk of bleeding in our patients’ cohort, and in particular the presence of cerebral microbleeds, we reported that patients with CMBs had higher circulating levels of TIMP-2 and TIMP-3 with respect to patients without CMBs, and this association also remained significant in a multivariate logistic analysis. Here, TIMP3 is linked to cerebral microbleeds.